Financhill
Back

Sarepta Therapeutics Quote, Financials, Valuation and Earnings

Sarepta Therapeutics Price Quote

$118.99
+0.02 (+-0.4%)
(Updated: December 21, 2024 at 5:48 AM ET)

Sarepta Therapeutics Key Stats

Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Day range:
$118.56 - $121.00
52-week range:
$91.34 - $173.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.30
P/B ratio:
9.31%

Volume:
1.7M
Avg. volume:
1.1M
1-year change:
31.76%
Market cap:
$11.4B
Revenue:
$1.2B
EPS:
$1.54

How Much Does Sarepta Therapeutics Make?

Data Unavailable

Is Sarepta Therapeutics Growing As A Company?

Data Unavailable

Sarepta Therapeutics Stock Price Performance

What Is Sarepta Therapeutics 52-Week High & Low?

Sarepta Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sarepta Therapeutics?

Data Unavailable

Is Sarepta Therapeutics Cash Flow Positive?

Data Unavailable

Sarepta Therapeutics Return On Invested Capital

Data Unavailable

Sarepta Therapeutics Earnings Date & Stock Price

Sarepta Therapeutics Competitors

  • Who Are Sarepta Therapeutics's Competitors?
    Below is a list of companies who compete with Sarepta Therapeutics or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Arrowhead Pharmaceuticals Inc (ARWR)
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Eli Lilly and Co (LLY)
    • Vertex Pharmaceuticals Inc (VRTX)

Sarepta Therapeutics Dividend Yield

Data Unavailable

Sarepta Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 66.97%
Revenue: 40.79% 15.33%

Analyst Recommendations

Buy Recommendations: 12
Hold Recommendations: 0
Sell Recommendations: 1
Price Target: 185.10
Upside from Last Price: 55.59%

Major Shareholders

Data Unavailable